Eli Lilly said Monday it entered into a definitive agreement to acquire biotechnology firm Orna Therapeutics, which focuses on engineering immune cells. Under the agreement, Orna shareholders may...
Eli Lilly Agrees to Acquire Immune Cell Engineering Company Orna Therapeutics for Up to $2.4 Billion
